Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
ALLO:NASDAQ
Allogene Therapeutics Inc
$2.31
-1.70%
(-0.040) 1D
$2.30
-0.43% (-0.0100)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALLO...
Open
$2.33
High
$2.38
Low
$2.26
Mkt. cap
761.41M
Avg. vol.
13.18M
Volume
5.53M
52-wk high
$4.46
52-wk low
$0.86
EPS
-$0.87
Beta
0.53
Shares outstanding
331.28M
No. of employees
150
News stories
From sources across the web
About Allogene Therapeutics Inc
CEO-
Employees150
Founded2017
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Last report
Mar 12, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.17/ (-0.22 est.)USD
+22.46%beat
Revenue / Estimate
-/ (2.00K est.)USD
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
50.20M
40.16M
31.16M
28.63M
Cost of revenue
50.20M
40.16M
31.16M
28.63M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.99M
14.28M
13.74M
13.77M
Operating expense
14.99M
14.28M
13.74M
13.77M
Total operating expenses
65.19M
54.44M
44.90M
42.40M
Operating income
-65.19M
-54.44M
-44.90M
-42.40M
Other non operating income
92.00K
-43.00K
-81.00K
247.00K
EBT including unusual items
-59.73M
-50.94M
-41.40M
-38.81M
EBT excluding unusual items
-59.73M
-48.56M
-41.40M
-38.81M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-59.73M
-50.94M
-41.40M
-38.81M
Net profit margin
-
-
-
-
Earnings per share
-0.28
-0.22
-0.19
-0.17
Interest and investment income
5.52M
6.19M
3.93M
3.66M
Interest expense
-150.00K
-268.00K
-344.00K
-313.00K
Net interest expenses
5.37M
5.92M
3.58M
3.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
-62.09M
-51.33M
-41.80M
-39.35M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more